Showing results (161-170 of 180) with videos related to
Sort By:
Pageof 18
Journal of the National Cancer Institute|February 5, 1998
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardiaW H Chow, W J Blot, T L Vaughan, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 23, 2015
Associations of Coffee Drinking with Systemic Immune and Inflammatory MarkersErikka Loftfield, Meredith S Shiels, Barry I Graubard, et al.Cancer Causes & Control : CCC|February 23, 2011
Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancerStephanie M George, Melinda L Irwin, Ashley W Smith, et al.Science (New York, N.Y.)|March 12, 2005
Complement factor H polymorphism in age-related macular degenerationRobert J Klein, Caroline Zeiss, Emily Y Chew, et al.Cancer Causes & Control : CCC|August 1, 2007
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomasMary Beth Terry, Marilie D Gammon, Fang Fang Zhang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based studyMarilie D Gammon, Mary Beth Terry, Nadir Arber, et al.The Journal of Clinical Endocrinology and Metabolism|December 2, 2010
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to knowA Catharine Ross, JoAnn E Manson, Steven A Abrams, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1998
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancerD C Farrow, T L Vaughan, P D Hansten, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2005
Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancersKatrina F Trivers, Anneclaire J De Roos, Marilie D Gammon, et al.Journal of the National Cancer Institute|September 18, 2003
Population attributable risks of esophageal and gastric cancersLawrence S Engel, Wong-Ho Chow, Thomas L Vaughan, et al.Pageof 18